Verve Therapeutics Cash Flow Statement 2019-2024 | VERV

Fifteen years of historical annual cash flow statements for Verve Therapeutics (VERV).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-200.07$-157.39$-120.31$-45.70$-19.30
$-8.93$1.78$3.04$1.71$0.03
$41.74$24.90$42.30$6.09$9.16
$32.82$26.68$45.35$7.80$9.19
$0$0$0$0$0
$0$0$0$0$0
$3.91$-5.22$6.83$-1.90$1.74
$14.02$6.56$-15.72$-1.53$-0.02
$17.70$8.38$-2.91$2.64$2.66
$-149.55$-122.33$-77.88$-35.27$-7.44
$-9.28$-13.23$-4.36$-3.42$-1.86
$0$0$0$0$0
$0$0$0$0$0
$36.97$-142.72$-234.74$-47.70$-10.90
$0$0$0$0$0
$36.97$-142.72$-234.74$-47.70$-10.90
$0$0$0$0$0
$27.69$-155.96$-239.10$-51.13$-12.76
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$213$330$287$0.01$0
$213$330$381$92.63$18.04
$0$0$0$0$0
$-0.46$-0.78$-3.63$0$-0.09
$213$329$377$92.63$17.95
$90.72$50.67$60.11$6.24$-2.25
$35.12$22.48$7.07$0.85$0.45
$0$0$0$0$0